Galectin Therapeutics
GALT
#7581
Rank
HK$3.01 B
Marketcap
HK$46.83
Share price
4.88%
Change (1 day)
215.17%
Change (1 year)

Earnings for Galectin Therapeutics (GALT)

Earnings in 2025 (TTM): -HK$0.32 Billion

According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.37 Billion a decrease over its 2023 earnings that were of -HK$0.32 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Galectin Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.32 Billion-14.18%
2024 -HK$0.37 Billion14.56%
2023 -HK$0.32 Billion5.91%
2022 -HK$0.31 Billion27.02%
2021 -HK$0.24 Billion30.1%
2020 -HK$0.19 Billion76.51%
2019 -HK$0.11 Billion-4.36%
2018 -HK$0.11 Billion-14.38%
2017 -HK$0.13 Billion-24.26%
2016 -HK$0.17 Billion7.04%
2015 -HK$0.16 Billion26.85%
2014 -HK$0.13 Billion30.61%
2013 -HK$94.04 Million27.82%
2012 -HK$73.57 Million-9.15%
2011 -HK$80.98 Million113.17%
2010 -HK$37.99 Million-19.86%
2009 -HK$47.4 Million14.4%
2008 -HK$41.44 Million-17.49%
2007 -HK$50.22 Million-8.41%
2006 -HK$54.83 Million5.91%
2005 -HK$51.78 Million-8.89%
2004 -HK$56.83 Million47.92%
2003 -HK$38.42 Million50.22%
2002 -HK$25.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Mirati Therapeutics
MRTX
-HK$5.96 Billion 1,796.11%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$0.23 B-176.31%๐Ÿ‡บ๐Ÿ‡ธ USA